Level Biotechnology Inc. (TPEX:3118)

Level Biotechnology Revenue

Level Biotechnology had revenue of 162.35M TWD in the quarter ending June 30, 2026, a decrease of -5.37%. This brings the company's total for the last twelve months to 709.37M, down -3.54% year-over-year. In the year 2025, Level Biotechnology had annual revenue of 736.59M with 0.72% growth. That makes Level Biotechnology the 33,294th largest company in the world by revenue and 1,714th in Taiwan.

• Revenue (ttm): 709.37M
• Revenue Growth: -3.54%
• P/S Ratio: 1.40
• Revenue / Employee: 5.54M
• Employees: 128
• Market Cap: 993.06M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Reagent Consumable Materials Trading 370.01M 50.2%
• Instrument and Equipment Trading 239.73M 32.5%
• Entrusted Biotechnology Service Sales 126.86M 17.2%

Fiscal year ended Dec 31, 2025 See the full Level Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	736.59M	5.25M	0.72%
Dec 31, 2024	731.35M	70.74M	10.71%
Dec 31, 2023	660.61M	67.60M	11.40%
Dec 31, 2022	593.01M	-84.27M	-12.44%
Dec 31, 2021	677.28M	4.79M	0.71%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error